39 related articles for article (PubMed ID: 19215346)
1. Mu-selective opioid peptides stimulate prolactin release in lactating rats.
Baumann MH; Rabii J
J Neuroendocrinol; 1990 Jun; 2(3):271-6. PubMed ID: 19215346
[TBL] [Abstract][Full Text] [Related]
2. The role of the mu(1) opioid receptor subtype in the regulation of prolactin and growth hormone secretion by Beta-endorphin in female rats: studies with naloxonazine.
Janik J; Callahan P; Rabii J
J Neuroendocrinol; 1992 Dec; 4(6):701-8. PubMed ID: 21554657
[TBL] [Abstract][Full Text] [Related]
3. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
[TBL] [Abstract][Full Text] [Related]
4. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
Tortella FC; Robles L; Mosberg HI
J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
[TBL] [Abstract][Full Text] [Related]
5. Effects of mu-opioid receptor stimulation in the hypothalamic paraventricular nucleus on basal and stress-induced catecholamine secretion and cardiovascular responses.
Kiritsy-Roy JA; Appel NM; Bobbitt FG; Van Loon GR
J Pharmacol Exp Ther; 1986 Dec; 239(3):814-22. PubMed ID: 3025420
[TBL] [Abstract][Full Text] [Related]
6. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
7. Neurotransmitters involved in the opioid regulation of prolactin secretion at the end of pregnancy in rats.
Soaje M; Bregonzio C; CarĂ³n RW; Deis RP
Neuroendocrinology; 2004; 80(1):11-20. PubMed ID: 15340248
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
Locke KW; Holtzman SG
J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
[TBL] [Abstract][Full Text] [Related]
9. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastoma cells.
Zadina JE; Harrison LM; Ge LJ; Kastin AJ; Chang SL
J Pharmacol Exp Ther; 1994 Sep; 270(3):1086-96. PubMed ID: 7932156
[TBL] [Abstract][Full Text] [Related]
10. Selective and interactive down-regulation of mu- and delta-opioid receptors in human neuroblastoma SK-N-SH cells.
Baumhaker Y; Gafni M; Keren O; Sarne Y
Mol Pharmacol; 1993 Aug; 44(2):461-7. PubMed ID: 8394999
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
Puttfarcken PS; Werling LL; Cox BM
Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
[TBL] [Abstract][Full Text] [Related]
12. Chronic morphine exposure during puberty induces long-lasting changes in opioid-related mRNA expression in the mediobasal hypothalamus.
Byrnes EM
Brain Res; 2008 Jan; 1190():186-92. PubMed ID: 18083149
[TBL] [Abstract][Full Text] [Related]
13. The effects of opiate agonists on growth hormone and prolactin release in rats.
Shaar CJ; Clemens JA
Fed Proc; 1980 Jun; 39(8):2539-43. PubMed ID: 6247214
[TBL] [Abstract][Full Text] [Related]
14. Activation of opioid receptors in the mediobasal hypothalamus stimulates prolactin secretion in the conscious rat.
Kapoor R; Willoughby JO
J Neuroendocrinol; 1990 Jun; 2(3):347-50. PubMed ID: 19215358
[TBL] [Abstract][Full Text] [Related]
15. Mu opiate receptor down-regulation by morphine and up-regulation by naloxone in SH-SY5Y human neuroblastoma cells.
Zadina JE; Chang SL; Ge LJ; Kastin AJ
J Pharmacol Exp Ther; 1993 Apr; 265(1):254-62. PubMed ID: 8097244
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of mu- and delta-receptor selective opioid agonists on feedforward and feedback GABAergic inhibition in hippocampal brain slices.
Lupica CR; Dunwiddie TV
Synapse; 1991 Aug; 8(4):237-48. PubMed ID: 1656539
[TBL] [Abstract][Full Text] [Related]
17. Intrahypothalamic Mu-, not Delta- or Kappa-Opioid Receptor Activation Causes Growth Hormone Secretion.
Willoughby JO; Kapoor R; Mackenzie L
J Neuroendocrinol; 1991 Apr; 3(2):149-54. PubMed ID: 19215516
[TBL] [Abstract][Full Text] [Related]
18. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area.
Latimer LG; Duffy P; Kalivas PW
J Pharmacol Exp Ther; 1987 Apr; 241(1):328-37. PubMed ID: 3033208
[TBL] [Abstract][Full Text] [Related]
19. Alterations in hypothalamic mu-opiate receptor-mediated responses but not methionine enkephalin or proenkephalin messenger RNA levels in rats with acute cholestasis.
Swain MG
Hepatology; 1994 Sep; 20(3):700-5. PubMed ID: 8076927
[TBL] [Abstract][Full Text] [Related]
20. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats.
Spencer RL; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1988 Jul; 246(1):92-101. PubMed ID: 2839673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]